FDA's new pharmaceutical quality initiative: Knowledge-aided assessment & structured applications

Area of Science:

• Pharmaceutical quality assessment
• Regulatory science
• Drug lifecycle management

Background:

• Current pharmaceutical quality assessment relies on text-based narratives.
• Need for standardized, efficient, and consistent regulatory oversight.
• Importance of drug quality for safety and efficacy.

Purpose of the Study:

• Introduce the Knowledge-aided Assessment & Structured Application (KASA) system.
• Describe KASA's design for capturing knowledge and performing risk assessments.
• Highlight KASA's role in advancing pharmaceutical quality.

Main Methods:

• Knowledge capture and management throughout the drug product lifecycle.
• Development of rules and algorithms for risk assessment and control.
• Computer-aided analysis of applications for regulatory standard comparison.
• Structured assessment minimizing text-based summarization.

Main Results:

• KASA system designed for comprehensive pharmaceutical quality assessment.
• Enables computer-aided analysis and structured regulatory review.
• Facilitates lifecycle management of drug products and facilities.

Conclusions:

• KASA enhances effectiveness, efficiency, and consistency in regulatory quality oversight.
• Standardized information sharing improves regulatory processes.
• KASA advances the FDA's focus on pharmaceutical quality, ensuring drug safety and efficacy.